dimethyl sulfoxide has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Leukemia, Myelomonocytic, Chronic: A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anzai, N | 1 |
| Kawabata, H | 1 |
| Hirama, T | 1 |
| Masutani, H | 1 |
| Ohmori, M | 1 |
| Yoshida, Y | 1 |
| Okuma, M | 1 |
1 other study available for dimethyl sulfoxide and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Marked apoptosis of human myelomonocytic leukemia cell line P39: significance of cellular differentiation.
Topics: Apoptosis; Calcimycin; Cell Differentiation; Dactinomycin; Dimethyl Sulfoxide; Humans; Leukemia, Mye | 1994 |